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Adult neural stem cells (NSCs) storing in thesubependyma and the back side of the hippoc-ampus region or being obtained through trans-
plantation can display specific tropism for injured brain
tissues and differentiate into neurons or glial cells un-
der the influence of brain micro-environment to recover
nerve function,1 but so far, the tropism mechanism of
NSCs for traumatic site is still unknown. Some studies
reported that stromal cell-derived factor-1 (SDF-1) played
an important role in “homing” and targeting migration of
hematopoietic precursor cells.2 This study aimed to ex-
plore how the SDF-1 plays its role during the stem cell
migration, as well as its tropism mechanism.
METHODS
Materials and reagents
Fetal bovine serum (FBS, Sijiqing Company,
Hangzhou), trypsin (Gibco, USA), Collagenase IV
(Sigma, USA), Transwell system (Corning, USA), rab-
bit anti-rat SDF-1 antibody (Zhongshan Company,
Beijing), goat anti-rat chemotatic factor receptor-4
(CXCR-4) antibody (Boshide Company, Wuhan), mouse
anti-rat antibody BrdU (Zhongshan Company, Beijing),
AMD3100 (Gibco, USA), Western blotting related re-
agents (Chemicon, USA), immunohistochemistry kits
(Boshide Company, Wuhan), newborn (aged 1-3 days)
and adult (weighing 300 g ± 25 g) male Sprague Dawley
(SD) rats purchased from the Beijing Academy of Mili-
tary Medical Sciences, raised in the animal laboratory
center of Medical College of the Chinese People’s
Armed Police Force, were employed in this study.
Isolation and primary culture of NSCs
We obtained the brain tissues of the newborn SD
rats. After rinsed with D-Hanks liquid, the meninges
were removed and the hippocampus was separated
accurately. Then the brain tissues were cut into pieces
and transferred into the serum-free medium with
Dulbecco’s minimum essential medium (DMEM)/F12
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Objective:    To explore the role and function of stromal
cell-derived factor-1 (SDF-1) in stem cells migrating into in-
jured brain area.
Methods:    Rat-derived nerve stem cells (NSCs) were
isolated and cultured routinely. Transwell system was used
to observe the migration ability of NSCs into injured nerve
cells. Immunocytochemistry was used to explore the expres-
sion of chemotactic factor receptor-4 (CXCR-4) in NSCs. In
vivo, we applied immunofluorescence technique to observe
the migration of NSCs into injured brain area. Immunofluo-
rescence technique and Western blotting were used to test
expression level of SDF-1. After AMD3100 (a special chemi-
cal blocker) blocking CXCR-4, the migration ability of NSCs
was tested in vivo and in vitro, respectively.
Results:    NSCs displayed specific tropism for injured
nerve cells or traumatic brain area in vivo and in vitro. The
expression level of SDF-1 in traumatic brain area increased
remarkably and the expression level of CXCR-4 in the NSCs
increased simultaneously. After AMD3100 blocking the ex-
pression of CXCR-4, the migration ability of NSCs decreased
significantly both in vivo and in vitro.
Conclusions:    SDF-1 may play a key role in stem cells
migrating into injured brain area through specially combin-
ing with CXCR-4.
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(1:1), B27, and basic fibroblast growth factor (bFGF,
20 ng/ml). Single cell suspension was prepared through
repeatedly blowing by a haustorial tube, then the con-
centration of cells was adjusted to 5 × 104-5 cells/ml.
The cell suspension was put into 24-well plates (500 µl
in each well) and cultured in a cell incubator at 37°C
with 5% CO2 and saturated humidity. After the neural
stem cells were cloned successfully, one passage was
separated through mechanical separation every 7 days.
Migration ability tests of NSCs in vitro
After the cultured NSCs were digested by trypsin,
the cell suspension was collected. About 1×104 NSCs
or NSCs adding AMD3100 blocking reagents were
planted into the up-room of the Transwell plate, and the
mixing cellular lysate of neurons and glia were added
into the down-room. Only phosphate buffered saline
(PBS) was planted in the blank control group. The num-
bers of NSCs migrated into the down-rooms were
counted 48 hours later.
Expression of CXCR-4 in NSCs measured by im-
munohistochemistry assay
NSCs in same number were cultured in the conven-
tional medium of DMEM/F12, the mixing cellular ly-
sate of neurons and glia, and DMEM/F12 adding
AMD3100 closing reagents, respectively. And 48 hours
later, the expression level of CXCR-4 in NSCs was
tested with immunohistochemical assay.3
Establishment of model of traumatic brain injury
in rats
All the experimental rats received intraperitoneal
injection of 10% chloral hydrate before fixed in a three-
dimensional frame. After fully exposing the rat skull, at
the rear of the former fontanelle of 2.4 mm and right to
the midline of 2.5 mm, a 4-mm-diameter bone window
was made and the integrity of the dura mater was
maintained, then a blow tube was fixed on the edge of
the bone window. A hydraulic head trauma instrument
was connected and the blow tube was kept close, then
an impact pressure of 0.24 MPa was given for 23 ms to
induce a craniocerebral injury.
Migration ability tests of NSCs in vivo
Three groups were designed in this part, including
NSCs transplant group, NSCs pre-treated by AMD3100
transplant group and the control group (NSCs were
transplanted into the brain area of non-traumatic rats).
In the NSCs pre-treated by AMD3100 transplant group,
NSCs were treated by AMD3100 to block CXCR-4 ex-
pression for 48 hours. And in all the three groups, NSCs
were labeled by BrdU 24 hours before transplantation.
A total of 10 µl cell suspension with the concentration
of 1 × 105  cells/µl was transplanted into the left brain
hemisphere of  al l  the rats. And 5 days af ter
transplantation, rat brain tissues were obtained to pre-
pare for the frozen or paraffin-embedded tissue slices
in storage. Then the frozen sections were used for im-
munofluorescence assay to observe the potential mi-
gration features of NSCs in vivo labeled by BrdU. In
details, the sections were first fixed by 4% paraformal-
dehyde at room temperature for 30 minutes. After be-
ing treated by 1% Triton X-100, the sections were bal-
anced in PBS for 3 minutes and repeated for 3 times,
then they were covered in goat serum for at least 30
minutes. After casting off the serum, 1:500 dilution of
BrdU antibody was dropped onto the tissue slices, which
were then incubated in waterlogged boxes at 4°C
overnight. Then 1:100 dilution of the second antibody
marked by rhodamine was added and the tissue slices
were incubated at 37°C for 45 minutes. Then they were
rinsed by PBS, dehydrated, covered by close solution,
and observed under a fluorescence microscope.
Immunofluorescence and Western blot assay to
test expression of SDF-1 on edge of injured area
Immunofluorescence assay was performed on the
paraffin sections as mentioned above, except for the
1:100 dilution of SDF-1 antibody. Western blot method
was performed as follows: the total protein of tissues
was extracted and quantitative analysis was made with
Lowry method. Then 50 µg protein was selected for
electrophoresis, coated after transmembrane, and in-
cubated in 1:200 dilution of anti-SDF-1 antibody
overnight. Then IgG antibody was labeled by horserad-
ish peroxidase (1:500 dilution) for 2 hours. X-ray film
was exposed moderately to reveal the intensity of SDF-1.
β-actin was taken as its inner reference. An absor-
bance scanner was used to detect the value of the peak
area in the absorption band images. The expression
levels of proteins were calculated with the following
formula:
Gray value of strip
Relative value of
protein expression
=
Gray value of refer-
ence samples
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Expression of CXCR-4 in NSCs
As shown in Fig.3, the brown cytoplasm shows
positive expression of CXCR-4. Picture A shows that
NSCs have a low expression level of CXCR-4 in con-
ventional culture medium. Picture B shows that NSCs
highly express CXCR-4 when cultured in the nerve cell
lysate. Picture C shows that NSCs have almost no ex-
pression of CXCR-4 by AMD3100 blocking effectively.
Migration ability of NSCs in vivo
Fig.4 shows the tropism characteristics of NSCs for
traumatic brain area in vivo through migration. The red
fluorescence located in the nucleus shows the trans-
planted NSCs pre-labeled by BrdU. We can see from Pic-
ture A, in the control group (no injury both in the left and
right brain hemispheres), there are no NSCs gathering in
the right brain hemisphere when the NSCs are transplanted
into the left brain hemisphere. Picture B shows that in the
right brain injury group there is a large number of NSCs
gathering in the right brain hemisphere when the NSCs
are transplanted into the left brain hemisphere. Picture C
shows that in the right brain injury group there is a small
number of NSCs gathering in the right brain hemisphere
when the NSCs pre-treated by AMD3100 are transplanted
into the left brain hemisphere.
Expression of SDF-1 on edge of traumatic brain
area
Fig.5 shows the results tested by immuno-fluorescence.
The red cytoplasm fluorescence shows positive expres-
sion of SDF-1 in brain tissues. Picture A shows that
there is a very low expression level of SDF-1 in the nor-
Statistical analysis
SPSS 13.0 statistical software was used for data
analysis. Comparison between two groups was made
by Student’s t test and multiple groups by ANOVA,
and P<0.05 had statistical significance.
RESULTS
Migration ability of NSCs in vitro
As shown in Fig.1, black spots show that there are
NSCs migrating into the down-room induced by the su-
pernatant fluid in the below room, and the hollow spots
show that no cell migration occurs. Picture A indicates
that there is no NSCs migration when NSCs are in the
up-room and PBS in the down-room. Picture B shows
that the number of NSCs migrating into the lower rooms
increase remarkably when NSCs are in the upper-room
and nerve cellular lysate in the lower-room. And Picture
C shows that, when NSCs pre-treated by AMD3100
blocking are in the upper-room and nerve cellular ly-
sate in the lower-room, the number of NSCs migrating
into the lower rooms is more than that in Picture A, but
fewer than that in Picture B (P<0.05). Fig. 2 shows the
comparison intuitively.
Fig.1. Transwell system for testing migration activity of NSCs to injured nerve cells (bar=20 µm). Black spots show that there are NSCs
migrating into the lower-room induced by the supernatant fluid in the lower room, and the hollow spots show that no cell migration occurs.
A: The upper-room for NSCs and the lower-room for PBS;  B: The upper-room for NSCs and the lower-room for nerve cellular lysate; C:
The upper-room for NSCs pre-treated by AMD3100 and the lower-room for nerve cells lysate.
Fig.2. Comparison of migration abilities of NSCs to injured nerve cells.
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mal brain area, but Picture B shows that the expres-
sion level increases remarkably where the brain is
injured. The result was consistent with that detected
by Western blot (Fig. 6).
DISCUSSION
Almost all the clinical treatments for patients in the
acute phase of traumatic brain injury are dealing with
its symptoms.4, 5 For the patients in the late phase, we
Fig.3. CXCR-4 expression when NSCs cultured in different conditions (IHC, bar=10 µm). A: NSCs have a low expression level of CXCR-
4 in the conventional culture medium (5.8%±2.7%); B: NSCs highly express CXCR-4 when cultured in the nerve cells lysate (48.4%± 12.
9%); C: NSCs have almost no expression of CXCR-4 after being blocked by AMD3100 effectively (0.8%±0.3%).
Fig.4. Distribution of NSCs pre-labeled by BrdU in site of injured brain tissues (IHC, bar=50 µm). A: There is no NSCs gathering in the right
brain hemisphere (without injury) when the NSCs are transplanted into the left brain hemisphere; B: There is a large number of NSCs
gathering in the right brain hemisphere (without injury) when the NSCs are transplanted into the left brain hemisphere; C: There is a small
number of NSCs gathering in the right brain hemisphere (without injury) when the NSCs pre-treated by AMD3100 are transplanted into the
left brain hemisphere.
Fig.5. Expression of SDF-1 at the limbic site of injured brain (IHC,
bar=50 µm). The red cytoplasm fluorescence shows positive ex-
pression of SDF-1 in brain tissues. A: Very low expression of
SDF-1 in brain tissues without injury;  B: Remarkably increased
expression of SDF-1 in traumatic brain tissues.
Fig.6. Expression of SDF-1 on the edge of injured brain tissues
detected with method of Western blotting. 1 and 2: Low expres-
sion of SDF-1 in brain tissues without injury; 3 and 4: Remarkably
increased expression of SDF-1 in injured brain tissues.
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always pay much more attention to their neurological
function recovery. And so far, many researchers around
the world have been working in the field of stem cell
transplantation in recent years. However, there still exist
following problems in treating brain injury with stem cell
transplantation:6-8 (1) whether these transplanted stem
cells can survive and proliferate under the conditions of
ischemia, hypoxia and a large number of toxin accu-
mulation in the local traumatic brain regions, (2) whether
stem cells under the influence of the brain micro-envi-
ronment can completely differentiate into nerve cells,
such as neurons and glial cells, and whether these dif-
ferentiated cells can display their normal electrophysi-
ological functions, and (3) how these stem cells can
reach the traumatic site and what its specific tropism
mechanism is, and so on. In this study, we are en-
gaged to analyze the potential mechanism of stem cells
migrating into the traumatic brain area.
SDF-1, a matrix secreting protein, widely exists in
many human tissues and organs. Its expression level
is significantly increased when the body suffers from
trauma, infection, inflammation, and so on. As a defen-
sive protein, SDF-1 can transport exogenous damage
signals into nucleated cells, induce their migration to
the injured site, and play such roles as phagocytosis,
transforming and repair.9,10 Studies have reported high
expression level of SDF-1 in traumatic brain tissues
and in vascular endothelial cells of several tumors.11, 12
Therefore, we speculated that stem cells may highly
express CXCR-4 receptors.
In this study, we detected widely the high expres-
sion of SDF-1 on the edge of traumatic brain tissues,
meanwhile, the NSCs exposed in the nerve cellular ly-
sate or brain micro-environment showed high expres-
sion level of CXCR-4. When SDF-1 and CXCR-4 were
both highly expressed at the same time, NSCs showed
much stronger migration ability. When using specific
chemical agent AMD3100 to block the expression of
CXCR-4, the migration ability of NSCs decreased
remarkably. Though the number of migrated stem cells
declined, we could not observe that the NSCs pre-
treated by AMD3100 stopped migrating completely.
Therefore, we predicted that the SDF-1/CXCR-4 axis
may play a certain role in the tropism of stem cells for
the injured brain area. However, this molecular event is
by no means the only one, much more known and un-
known factors are involved in this complex process.
Ni et al13 found that there was high expression level
of CXCR-4 in the neural progenitor cells and confirmed
that CXCR-4 played a certain role when the migration
of neural progenitor cells occurred during the develop-
ment of central nervous system. Subsequently, Son et
al14 started a research on the expression profiles of
CXCR-4, c-met and metalloproteinase (MMP) family of
mesenchymal stem cells from two different tissues
(bone marrow and cord blood). The results showed that
both CXCR4 and c-met mRNA were in high level in the
course of transcription, but the protein level was rela-
tively low. It may be related to its intracellular location
as well as the activation degree. When SDF-1 and hepa-
tocyte growth factor (HGF) increased in the surround-
ing environment, the densities of CXCR4 and c-met re-
ceptors in stem cells increased remarkably and showed
a clear dose-dependence. In addition, stem cells can
migrate through matrix barriers. Furthermore, these
stem cells can produce matrix-degrading enzyme, and
Son et al14 found that there was a certain extent of ex-
pression of matrix MMP-2 and membrane type-1 ma-
trix MMP (MT1-MMP) in the above-mentioned two stem
cell lines. Through inhibiting the expression of MT1-
MMP protein, the ability of the mesenchymal stem cells
in the umbilical cord blood passing through the matrix
barriers is dropped by 56%-67%. These studies showed
that SDF-1/CXCR4 axis, HGF-c-met axis, and the MMP
family may play some important roles in the process of
stem cells migrating for the injured brain area.
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